Sunitha Araamudhu
Known title: SVP - AIUSCIK: 0002039911
Associated companies
Transaction History
| PRDO | ▼ Sell | Tax Withholding | 839 | $30K | 3/14/2026 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 666 | $24K | 3/14/2026 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 862 | $31K | 3/14/2026 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 4,701 | $168K | 3/14/2026 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 5,336 | $0 | 3/14/2026 | View on chart |
| PRDO | ▲ Buy | Grant | 7,549 | $0 | 3/10/2026 | View on chart |
| PRDO | ▲ Buy | Grant | 7,549 | $0 | 3/10/2026 | View on chart |
| PRDO | ▼ Sell | Open Market | 14,296 | $439K | 5/23/2025 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 7,160 | $0 | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 600 | $15K | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 119 | $3K | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 596 | $15K | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 480 | $12K | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 4,259 | $105K | 3/14/2025 | View on chart |
| PRDO | ▲ Buy | Grant | 8,209 | $0 | 3/6/2025 | View on chart |
| PRDO | ▲ Buy | Grant | 8,209 | $0 | 3/6/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 24, 2026
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline
Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline. Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.